PAVmed (PAVM) Other financing activities (2018 - 2024)

PAVmed has reported Other financing activities for 6 years, with the latest figure at $62000.0 in Q1 2024.

• On a quarterly basis, Other financing activities fell 65.93% year-over-year to $62000.0 in Q1 2024; TTM through Dec 2024 was $62000.0, a 76.06% decrease from a year earlier, with the FY2024 full-year figure at $62000.0, down 76.06% from the prior year.
• Other financing activities was $62000.0 for Q1 2024 at PAVmed, down from $77000.0 in the prior quarter.
• The five-year high for Other financing activities was $57.9 million in Q4 2021, with the low at $12000.0 in Q1 2020.
• Average Other financing activities over 5 years is $5.7 million, with a median of $182000.0 recorded in 2023.
• The sharpest annual moves came in 2021 and 2022: Other financing activities soared 11366.67% in 2021, then tumbled 95.86% in 2022.
• Over 5 years, Other financing activities stood at $12000.0 in 2020, then surged by 482275.0% to $57.9 million in 2021, then slumped by 99.9% to $55000.0 in 2022, then soared by 40.0% to $77000.0 in 2023, then retreated by 19.48% to $62000.0 in 2024.
• The last three Other financing activities figures came in at $62000.0 (Q1 2024), $77000.0 (Q3 2023), and $182000.0 (Q1 2023), per Business Quant data.